COVID-19 in special populations.
作者信息
Yahav Dafna
机构信息
Infectious Diseases Unit, Sheba Medical Center, Ramat Gan, Israel; Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
出版信息
Clin Microbiol Infect. 2022 Jun;28(6):771-772. doi: 10.1016/j.cmi.2022.02.038. Epub 2022 Mar 10.
Abstract
摘要
相似文献
1
COVID-19 in special populations.特殊人群中的新型冠状病毒肺炎
Clin Microbiol Infect. 2022 Jun;28(6):771-772. doi: 10.1016/j.cmi.2022.02.038. Epub 2022 Mar 10.
2
High SARS-CoV-2 Seroprevalence in Rural Peru, 2021: a Cross-Sectional Population-Based Study.秘鲁农村地区 2021 年 SARS-CoV-2 血清阳性率高：一项基于人群的横断面研究。
mSphere. 2021 Dec 22;6(6):e0068521. doi: 10.1128/mSphere.00685-21. Epub 2021 Nov 24.
3
CRACoV-HHS: an interdisciplinary project for multi-specialist hospital and non-hospital care for patients with SARS-CoV-2 infection as well hospital staff assessment for infection exposure.CRACoV-HHS：一个跨学科项目，旨在为 SARS-CoV-2 感染患者提供多专科医院和非医院护理，以及对感染暴露的医院工作人员进行评估。
Folia Med Cracov. 2021 Dec 28;61(4):5-44. doi: 10.24425/fmc.2021.140002.
4
Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA in Blood of Patients With Coronavirus Disease 2019 (COVID-19): What Does It Mean?2019冠状病毒病（COVID-19）患者血液中严重急性呼吸综合征冠状病毒2（SARS-CoV-2）RNA的检测：这意味着什么？
Clin Infect Dis. 2021 Nov 2;73(9):e2898-e2900. doi: 10.1093/cid/ciaa1316.
5
Analytical and Clinical Analysis of Two Automated Anti-SARS-CoV-2 Immunoassays in Pre-Pandemic and Pandemic Patient Populations.在大流行前和大流行期间的患者人群中对两种自动化抗 SARS-CoV-2 免疫分析的分析和临床分析。
J Appl Lab Med. 2021 Mar 1;6(2):441-450. doi: 10.1093/jalm/jfaa204.
6
The Neuroimmune Pharmacology of SARS-CoV-2.新型冠状病毒的神经免疫药理学。
J Neuroimmune Pharmacol. 2021 Dec;16(4):699-705. doi: 10.1007/s11481-021-10038-z. Epub 2021 Dec 22.
7
Sero-Prevalence of SARS-CoV-2 Antibodies in High-Risk Populations in Vietnam.越南高危人群中 SARS-CoV-2 抗体的血清阳性率。
Int J Environ Res Public Health. 2021 Jun 11;18(12):6353. doi: 10.3390/ijerph18126353.
8
The Rapid Antigen Detection Test for SARS-CoV-2 Underestimates the Identification of COVID-19 Positive Cases and Compromises the Diagnosis of the SARS-CoV-2 (K417N/T, E484K, and N501Y) Variants.SARS-CoV-2 的快速抗原检测试验低估了 COVID-19 阳性病例的检出率，影响了对 SARS-CoV-2（K417N/T、E484K 和 N501Y）变异株的诊断。
Front Public Health. 2022 Jan 3;9:780801. doi: 10.3389/fpubh.2021.780801. eCollection 2021.
9
Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis.病毒-宿主相互作用组和蛋白质组学调查揭示了影响 SARS-CoV-2 发病机制的潜在毒力因子。
Med. 2021 Jan 15;2(1):99-112.e7. doi: 10.1016/j.medj.2020.07.002. Epub 2020 Jul 21.
10
Testing for SARS-CoV-2 at the core of voluntary collective isolation: Lessons from the indigenous populations living in the Amazon region in Ecuador.在自愿集体隔离的核心进行 SARS-CoV-2 检测：来自厄瓜多尔亚马逊地区土著居民的经验教训。
Int J Infect Dis. 2021 Apr;105:234-235. doi: 10.1016/j.ijid.2021.02.039. Epub 2021 Feb 13.
引用本文的文献
1
Role of leukocytes and systemic inflammation indexes (NLR, PLR, MLP, dNLR, NLPR, AISI, SIR-I, and SII) on admission predicts in-hospital mortality in non-elderly and elderly COVID-19 patients.白细胞及全身炎症指标（中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值、单核细胞与淋巴细胞比值、动态中性粒细胞与淋巴细胞比值、中性粒细胞与淋巴细胞比值乘积、急性炎症严重指数、全身炎症反应指数-I和全身炎症反应指数）在入院时的作用可预测非老年和老年COVID-19患者的院内死亡率。
Front Med (Lausanne). 2022 Aug 18;9:916453. doi: 10.3389/fmed.2022.916453. eCollection 2022.
本文引用的文献
1
Caring for older adults during the COVID-19 pandemic.在 COVID-19 大流行期间照顾老年人。
Clin Microbiol Infect. 2022 Jun;28(6):785-791. doi: 10.1016/j.cmi.2022.02.040. Epub 2022 Mar 11.
2
An overview of COVID-19 in solid organ transplantation.COVID-19 在实体器官移植中的概述。
Clin Microbiol Infect. 2022 Jun;28(6):779-784. doi: 10.1016/j.cmi.2022.02.005. Epub 2022 Feb 18.
3
Vaccines alone will not prevent COVID-19 outbreaks among migrant workers-the example of meat processing plants.仅靠疫苗无法防止农民工群体中出现 COVID-19 疫情——肉类加工厂为例。
Clin Microbiol Infect. 2022 Jun;28(6):773-778. doi: 10.1016/j.cmi.2022.02.004. Epub 2022 Feb 19.
4
A systematic review assessing the under-representation of elderly adults in COVID-19 trials.一项系统评价评估了 COVID-19 试验中老年人代表性不足的问题。
BMC Geriatr. 2020 Dec 20;20(1):538. doi: 10.1186/s12877-020-01954-5.
Zotero 插件